127 related articles for article (PubMed ID: 31296375)
1. Exploring the effects of BCG vaccination in patients diagnosed with tuberculosis: Observational study using the Enhanced Tuberculosis Surveillance system.
Abbott S; Christensen H; Lalor MK; Zenner D; Campbell C; Ramsay ME; Brooks-Pollock E
Vaccine; 2019 Aug; 37(35):5067-5072. PubMed ID: 31296375
[TBL] [Abstract][Full Text] [Related]
2. Observational study to estimate the changes in the effectiveness of bacillus Calmette-Guérin (BCG) vaccination with time since vaccination for preventing tuberculosis in the UK.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Trinder L; Smith PG; Fine PE; Sterne J; Abubakar I; Vynnycky E; Watson J; Elliman D; Lipman M; Rodrigues LC
Health Technol Assess; 2017 Jul; 21(39):1-54. PubMed ID: 28738015
[TBL] [Abstract][Full Text] [Related]
3. Modelling the effect of discontinuing universal Bacillus Calmette-Guérin vaccination in an intermediate tuberculosis burden setting.
Fu H; Lin HH; Hallett TB; Arinaminpathy N
Vaccine; 2018 Sep; 36(39):5902-5909. PubMed ID: 30143270
[TBL] [Abstract][Full Text] [Related]
4. Estimating the effect of the 2005 change in BCG policy in England: a retrospective cohort study, 2000 to 2015.
Abbott S; Christensen H; Welton NJ; Brooks-Pollock E
Euro Surveill; 2019 Dec; 24(49):. PubMed ID: 31822330
[TBL] [Abstract][Full Text] [Related]
5. Safety and Immunogenicity of Early Bacillus Calmette-Guérin Vaccination in Infants Who Are Preterm and/or Have Low Birth Weights: A Systematic Review and Meta-analysis.
Badurdeen S; Marshall A; Daish H; Hatherill M; Berkley JA
JAMA Pediatr; 2019 Jan; 173(1):75-85. PubMed ID: 30476973
[TBL] [Abstract][Full Text] [Related]
6. Impact of BCG vaccination on incidence of tuberculosis disease in southern Ireland.
Sweeney E; Dahly D; Seddiq N; Corcoran G; Horgan M; Sadlier C
BMC Infect Dis; 2019 May; 19(1):397. PubMed ID: 31072396
[TBL] [Abstract][Full Text] [Related]
7. [Progress in research of bacillus calmette-guerin vaccination and repeated vaccination].
You NN; Liu Q; Zhu LM; Lu W
Zhonghua Liu Xing Bing Xue Za Zhi; 2018 Nov; 39(11):1519-1523. PubMed ID: 30462965
[TBL] [Abstract][Full Text] [Related]
8. The role of BCG vaccine in the prevention and control of tuberculosis in the United States. A joint statement by the Advisory Council for the Elimination of Tuberculosis and the Advisory Committee on Immunization Practices.
MMWR Recomm Rep; 1996 Apr; 45(RR-4):1-18. PubMed ID: 8602127
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of BCG vaccination of the newborn: evaluation by a follow-up study of contacts in Bangui.
Lanckriet C; Lévy-Bruhl D; Bingono E; Siopathis RM; Guérin N
Int J Epidemiol; 1995 Oct; 24(5):1042-9. PubMed ID: 8557438
[TBL] [Abstract][Full Text] [Related]
10. Effectiveness of the Bacillus Calmette-Guerin vaccine in an Indonesian population with D543N NRAMP1 polymorphism.
Putera I; Pakasi TA; Syahmar I; Bramantyo AA; Karyadi E; Melani A; Sahiratmadja E
J Infect Dev Ctries; 2015 Jan; 9(1):42-7. PubMed ID: 25596570
[TBL] [Abstract][Full Text] [Related]
11. Neonatal BCG vaccination and child survival in TB-exposed and TB-unexposed children: a prospective cohort study.
Thysen SM; Benn CS; Gomes VF; Rudolf F; Wejse C; Roth A; Kallestrup P; Aaby P; Fisker A
BMJ Open; 2020 Feb; 10(2):e035595. PubMed ID: 32114478
[TBL] [Abstract][Full Text] [Related]
12. The lack of association between bacille Calmette-Guerin vaccination and clustering of Aboriginals with tuberculosis in western Canada.
Cook VJ; Hernández-Garduño E; Kunimoto D; Hershfield ES; Fanning EA; Hoeppner VH; Elwood RK; FitzGerald JM;
Can Respir J; 2005 Apr; 12(3):134-8. PubMed ID: 15875064
[TBL] [Abstract][Full Text] [Related]
13. A review of the literature on the economics of vaccination against TB.
Tu HA; Vu HD; Rozenbaum MH; Woerdenbag HJ; Postma MJ
Expert Rev Vaccines; 2012 Mar; 11(3):303-17. PubMed ID: 22380823
[TBL] [Abstract][Full Text] [Related]
14. The duration of protection of school-aged BCG vaccination in England: a population-based case-control study.
Mangtani P; Nguipdop-Djomo P; Keogh RH; Sterne JAC; Abubakar I; Smith PG; Fine PEM; Vynnycky E; Watson JM; Elliman D; Lipman M; Rodrigues LC
Int J Epidemiol; 2018 Feb; 47(1):193-201. PubMed ID: 29025083
[TBL] [Abstract][Full Text] [Related]
15. Early versus late BCG vaccination in HIV-1-exposed infants in Uganda: study protocol for a randomized controlled trial.
Nankabirwa V; Tumwine JK; Namugga O; Tylleskär T; Ndeezi G; Robberstad B; Netea MG; Sommerfelt H
Trials; 2017 Mar; 18(1):152. PubMed ID: 28359325
[TBL] [Abstract][Full Text] [Related]
16. Induction of mycobacterial protective immunity by sublingual BCG vaccination.
Eickhoff CS; Blazevic A; Killoran EA; Morris MS; Hoft DF
Vaccine; 2019 Aug; 37(36):5364-5370. PubMed ID: 31331776
[TBL] [Abstract][Full Text] [Related]
17. [BCG vaccines for the prevention of tuberculosis in the world].
Hashimoto T
Kekkaku; 1997 Nov; 72(11):629-37. PubMed ID: 9423301
[TBL] [Abstract][Full Text] [Related]
18. Prime-boost vaccination with Bacillus Calmette Guerin and a recombinant adenovirus co-expressing CFP10, ESAT6, Ag85A and Ag85B of Mycobacterium tuberculosis induces robust antigen-specific immune responses in mice.
Li W; Li M; Deng G; Zhao L; Liu X; Wang Y
Mol Med Rep; 2015 Aug; 12(2):3073-80. PubMed ID: 25962477
[TBL] [Abstract][Full Text] [Related]
19. Mucosal BCG Vaccination Induces Protective Lung-Resident Memory T Cell Populations against Tuberculosis.
Perdomo C; Zedler U; Kühl AA; Lozza L; Saikali P; Sander LE; Vogelzang A; Kaufmann SH; Kupz A
mBio; 2016 Nov; 7(6):. PubMed ID: 27879332
[TBL] [Abstract][Full Text] [Related]
20. Lack of immune responses to Mycobacterium tuberculosis DosR regulon proteins following Mycobacterium bovis BCG vaccination.
Lin MY; Geluk A; Smith SG; Stewart AL; Friggen AH; Franken KL; Verduyn MJ; van Meijgaarden KE; Voskuil MI; Dockrell HM; Huygen K; Ottenhoff TH; Klein MR
Infect Immun; 2007 Jul; 75(7):3523-30. PubMed ID: 17502400
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
